Full title: Phase I-II Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas
Age: 12-80
Phase: 1 and 2
Locations: University College London Hospitals
The trial is a phase II, single-arm, six-cohort, non-randomized, open-label, multicentre prospective study. It is for people whose soft tissue sarcoma or bone sarcoma has come back after treatment.
This trial is looking at two different types of treatment called sunitinib and nivolumab. Sunitinib is a type of targeted drug, and nivolumab is a type of immunotherapy.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
